KUALA LUMPUR, April 26 (Bernama) -- Ekso Bionics, an exoskeleton solutions developer, with its Asia headquarters in Singapore, has announced partnership with Australia’s Royal Rehab, further scaling the use of its robotic exoskeleton across the Asia Pacific region.
According to a statement, Ekso is the most clinically-used robotic exoskeleton in Asia and globally, and has helped patients take over 130 million steps globally.
With Ekso Bionics’ recent expansion plan in Asia Pacific, EksoNRs are already present in Singapore, Malaysia, Taiwan and Hong Kong.
On the other hand, Royal Rehab, Australia’s leading provider of rehabilitation and disability support services, has entered into an agreement with Ekso Bionics to bring its advanced exoskeleton technology to Australia.
Royal Rehab Chief Executive Officer, Matt Mackay said: “Breakthroughs in technology are driving better and faster outcomes for people living with life-changing conditions and injury; however, these have been unavailable in Australia, until now.
“It is our vision to create a centre of excellence in rehabilitation technology which will empower people with disabilities with an unparalleled level of freedom, choice and independence.”
Royal Rehab is also in discussions with Ekso Bionics to act as the demonstration site of the EksoNR for other rehabilitation providers in the Australian market in the future.
The EksoNR is set to revolutionise rehabilitation practice in Singapore and Asia with its ability to help improve patient recovery following stroke, acquired brain injury and spinal cord injury.
In Singapore, stroke is the leading cause of long-term disability and loss of mobility, especially amongst the seniors. Singapore faces 20 new strokes daily.
-- BERNAMA
No comments:
Post a Comment